cerebrovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >18 years old <80 years old, male or non-pregnant female; 2. Patients with cerebrovascular disease who are eligible for cerebral angiography or interventional therapy; 3. Expected survival period ? 3 months; 4. The function of major organs is normal; 5. The subjects are willing to join the study, sign the informed consent form, have good compliance, and cooperate with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Severe radial artery, brachial artery, subclavian artery, brachiocephalic artery, iliac artery, or common femoral artery stenosis, determined by physical examination and ultrasonography that may obstruct the passage of the guide wire; unpalpable radial artery or negative; 2. Contraindications for angiography, such as severe heart, lung, or kidney disease; those who are allergic to or intolerable to contrast media; those who cannot keep supine for a long time; those who have abnormal coagulation function and have a tendency to bleeding; 3. Investigators believe that they are not suitable for inclusion: women who are pregnant and breastfeeding; patients who have recently received radial artery access for diagnosis and treatment; those who have participated in clinical trials of other drugs or medical devices before enrollment but did not reach the primary study endpoint time limit; 4. Ruptured aneurysm (patients with Hunt-Hess>3) or combined with large intracranial hematoma may be life-threatening; 5. Patients who were admitted and discharged within 24 hours, those who could not complete the ultrasound examination and those who refused ultrasound follow-up; 6. Patients who cannot receive antiplatelet aggregation or anticoagulation therapy; 7. The investigators believe that patients who are not suitable to participate in or continue to participate in this clinical trial or patients who automatically withdraw from the protocol in the middle of the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| radial artery occlusion; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sheath insertion success rate;total fluoroscopy time;number of crossovers; | — |
Countries
China
Contacts
Shanghai East Hospital, School of Medicine, Tongji University